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The binding of a homologous eries of alkyl-linked 4-aminodiquinolines to circular and linear DNAs was studied using 
viscometric titrations and equilibrium dialysis. The compounds are monofunctional intercalators with the capacity for 
intercalative binding reaching a peak for the heptane homologue. They show marked AT-base pair selectivity, which 
suggests that the non-intercalated quinoline ring may lie in the DNA minor groove. Affinities for calf thymus DNA in- 
crease as the alkyl chain is lengthened, falling in the range 6 to >250 x l(P M-r in a buffer of Z 0.01. The association 
constant of the heptane diquinoline decreases with increasing ionic strength, 2.1 cations being released per bound diposi- 
tive ligand molecule. All the agents are growth inhibitory towards mouse leukemia cells in culture with IC,, values in 
the range 0.0618 ,uM. 
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1. INTRODUCTION 
Many compounds which bind to DNA by inter- 
calation are useful chemotherapeutic agents and 
much effort has gone into defining the structural 
requirements for intercalative binding. It has 
generally been accepted that three fused aromatic 
rings constitute an optimum flat area for intercala- 
tion, and aminoacridines, for example, are ar- 
chetypal DNA-intercalating ligands. In contrast, 
quinolines like chloroquine are poor intercalators 
[ 11. Among the many studies of acridines are those 
(review [2]) that have established the necessary 
structural requirements for bifunctional intercala- 
tion of 9-aminoacridine dimers, and the N,N’-bis- 
(4-acridinyl)a,w-diaminoalkanes [2] stand as type- 
specific bisintercalating agents. Interestingly, the 
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bisintercalating members of this series have an- 
titumour activity whereas the monofunctional 
dimers and 9aminoacridine do not [2]. The 
quinoline analogues of these compounds have also 
been synthesized, and have been evaluated as an- 
tibacterial and antileprotic agents [3]. In addition, 
they are known to be potent and selective ligands 
for cY-adrenoceptors [4]. The structurally related, 
ring-substituted, bisquinaldines have antimalarial 
[5] and antitumour activity [6]. Despite the 
chemotherapeutic properties of binuclear quino- 
lines, and evidence that they interfere with nucleic 
acid metabolism [2], no detailed study of their 
binding to DNA has been reported. Here we ex- 
amine the mode, strength and specificity of DNA 
binding of the homologous series of N,N’bis- 
(Cquinolyl)-cu,w-diaminoalkanes (fig. l), in order 
both to evaluate the importance of chromophore 
surface area as a determinant of the capacity to 
bisintercalate and to investigate the relationship 
between biological activity and the mode of bin- 
ding for diquinolines. 
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Fig. 1. Structure of the N,N ‘-bis(4-quinolyl)-cY,w-diamino- 
alkanes. Compounds are referred to by the pseudonym C, 
where n is the number of carbon atoms in the linker chain. 
2. MATERIALS AND METHODS 
Experiments were conducted in Hepes/NaOH buffers at pH 
7.0 containing 2 mM Hepes, 10pM EDTA and sufficient NaCl 
to yield the required ionic strength. This solvent is referred to 
below as SHE buffer. Calf thymus and bacterial DNAs were 
purchased from Sigma. A strain of the E. coli bacterium bear- 
ing the plasmid pNZ116 (miniF inserted at the EcoRI site in 
pBR322, 50% G + C) was provided by Professor H.E.D. Lane, 
Auckland University, and closed circular DNA prepared from 
it by standard procedures. DNA concentrations were deter- 
mined with respect o base pairs using an E~,x, value of 13 200 
M-l. cm-‘, and all binding ratios (r) and affinity constants are 
expressed in base pair units. The bisquinolines were synthesized 
and purified as the crystalline hydrated dihydrochlorides 
following the method of Deshpande and Singh [3]. Full syn- 
thetic details will be reported elsewhere. Binding affinities and 
sequence selectivities were measured by equilibrium dialysis us- 
ing established procedures (71. When determining binding 
isotherms, free ligand concentrations were measured spec- 
trophotometrically using the molar absorption coefficients 
shown in table 1. On the DNA side of the dialysis cell the com- 
plex was dissociated by adding SDS to a final concentration of 
1% and the total drug concentration determined using the 
molar absorption coefficients for 1% SDS-buffer mixtures 
listed in table 1. Dialysis equilibrium was established within 20 
h at 20°C. Viscometric titrations were performed according to 
published methods [7]. Sonicated calf thymus DNA at a con- 
centration of 300 pM was used in the helii extension 
measurements. When measuring helix unwinding angles 
pNZl16 DNA was used at the lower concentration of 100 pM. 
The ability of the compounds to inhibit the growth of murine 
leukaemia L1210 cells in culture was assessed as described [8]. 
3. RESULTS 
The spectroscopic data reported in table 1 reveal 
bathochromic shifts in ligand absorption spectra 
on binding to calf thymus DNA in a buffer of I 
0.01. For Caminoquinoline and the C6-Cl0 di- 
quinolines this is accompanied by hypochromicity 
in each spectral band, whereas for the lower 
homologues in the series both hypo- and hyper- 
Table 1 
Spectral properties, association constants and specificity data for the diquinolines 
Compound Free ligand 
h (nm) E x 10-4 
(M-r. cm-r) 
DNA-bound SHE/l% SDS Binding Specificity 
h (nm) l x 10-4 A (nm) E x 1o-4 
constant Ly 
(M-l. cm-‘) (M-’ . cm-‘) 
K(0, x 10-4 
(M-l) 
4Aminoquinoline 
c2 
c4 
CS 
C6 
c7 
C8 
c9 
Cl0 
335 1.13 336 0.765 
322 1.26 323 0.802 
344 1.91 346 2.19 
329 1.79 335 1.87 
342 1.28 343 1.77 
327 2.00 330 1.71 
342 1.72 343 2.00 
326 2.56 330 1.92 
342 1.78 343 1.74 
327 2.23 330 1.69 
342 2.89 343 2.18 
328 3.05 331 2.13 
342 2.49 344 1.80 
328 2.58 331 1.76 
343 3.22 343 2.58 
328 3.24 331 2.19 
343 2.39 344 1.44 
329 2.65 332 1.35 
337 1.18 
346 3.86 
345 3.16 
343 3.54 
343 2.81 
343 3.91 
343 2.91 
343 4.24 
343 2.89 
0.5 - 
6.0 0.25 
6.0 0.20 
6.0 - 
10 0.22 
160 (0.01) 0.55 
2.3 (0.1) 
0.26 (0.3) 
> 250 0.35 
> 250 _ 
> 250 0.50 
Molar absorption coefficients were measured in a 0.01 SHE buffer at a ligand concentration of 5 PM. Spectra of the ligands bound 
to calf thymus DNA were recorded at r = 0.025. Binding measurements were conducted in a 0.01 SHE buffer at 20°C unless otherwise 
indicated, and (Y values determined in a 0.1 SHE buffer at 20°C 
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chromic effects are found. The C7 diquinoline 
showed no deviation from Beer’s Law up to 1 mM 
at the ionic strengths used for binding studies. This 
indicates that intermolecular aggregation, a 
feature of numerous heteroaromatic hromopho- 
res such as acridines [9] and phenanthridines [lo], 
does not occur to any significant extent. Similarly, 
solutions of 4-aminoquinoline also showed no 
evidence of aggregation under these conditions. 
Scatchard plots for the interaction of C7 di- 
quinoline with calf thymus DNA in SHE buffers of 
L 
0 
A 
6- 
0.1 0.2 0.3 0.4 
r 
10.01, 0.1 and 0.3 at 20°C are shown in fig.2. The 
Kco) values at IO. 1 and IO.3 of 2.3 x lo4 M-i and 
0.26~ lo4 M-’ respectively, were derived from a 
linear least-squares fit to eqn 10 of McGhee and 
Von Hippel [ll]. The data at I 0.01 are not 
amenable to this analysis which corresponds to a 
simple excluded site model. In this situation the in- 
trinsic association constant to an isolated binding 
site &, can be estimated by extrapolation to the 
ordinate axis [l l] yielding a value for Kco) of 
160 x 104 M-i at 10.01. Affinity is weakened by an 
3 
0 
2 
Q” * 
‘0 
1 
0 
0 
0 0.05 0.10 0.15 0.20 
, 
Fig.2. Scatchard plots for the binding of C7 diquinoline to calf 
thymus DNA in a buffer of 10.01 (A), 10.10 (B) and 10.30 (C) 
at 20°C. Inset to A: plot of log Kc01 versus log,[Na+]. 
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increase in cation concentration and a linear rela- 
tionship between log &,) and log [Na+] is observed 
(fig.2A) consistent with polyelectrolyte theory as 
developed by Friedman and Manning [12] and 
Record et al. [13]. The latter treatment may be 
used to estimate whether binding of the dicationic 
C7 ligand takes place with the concomitant release 
of 2.1 Na+ from the condensation sheath of DNA. 
Binding parameters for 4-aminoquinoline and the 
other bisquinolines were estimated in the same way 
(not shown) and the Kc,,) values so obtained at I 
0.01 and 20°C are recorded in table 1. Across the 
series there is a marked increase in association con- 
stant with increasing chain length: notable jumps 
in affinity occur for C2 diquinoline compared to 
4-aminoquinoline and for C7 diquinoline com- 
pared to the C6 and lower homologues. 
The nucleotide sequence selectivity of the di- 
quinolines was assessed by partition dialysis using 
DNAs from Micrococcus lysodeikticus DNA (72% 
G + C) and Clostridium perfringens (30% G + C) 
in a buffer of I 0.1. The parameter cy’ [14], the 
ratio of the r values for the two DNAs in 
equilibrium with the same free drug concentration, 
was determined at three ligand to DNA input 
ratios for each compound. The plot of cy’ versus r 
for M. lysodeikticus DNA was extrapolated to r = 
0 to yield a, which is the ratio of the affinity for 
M. lysodeikticus DNA to the affinity for Cl. per- 
fringens DNA [ 141. cy ’ values were obtained at 
binding ratios up to 0.03 and are found to decrease 
as r approaches zero, except in the case of Cl0 di- 
quinoline where a’ is independent of the degree of 
binding. The measured cy values are presented in 
table 1 and indicate that the diquinolines show a 
marked AT-selectivity. Where optimum binding 
requires one AT base pair at the binding site (Y is 
theoretically equal to the ratio of the A + T content 
of AJ. Iysodeikticus DNA to that of Cl. perfringens 
DNA (0.4). If two AT pairs were required a would 
be equal to the ratio of the square of the A + T con- 
tent of the respective DNAs (0.16). The LY values 
found for C2, C4 and C6 diquinoline suggest hat 
at least some binding sites for these ligands contain 
more than one AT base pair. Binding of 
4-aminoquinoline was undetectable in a buffer of 
IO.1. 
The capacity of 4-aminoquinoline and its dimers 
to intercalate was determined by their ability to in- 
crease the contour length of sonicated calf thymus 
DNA fragments, and to remove and reverse the 
supercoiling of covalently closed circular DNA in 
a buffer of 10.01. Helix extension parameters and 
unwinding angles are reported in table 2. 
Measurements were made in duplicate for each 
ligand, and input ratios in helix extension plots 
Table 2 
Intercalation parameters and growth inhibition properties of diquinolines 
Compound Helix extension Helix unwinding Growth inhibition, 
parameter angle (“) Go kM) 
4AQ 0.60 i 0.10 8.0 i 0.5 >25 
c2 0.25 * 0.05 11.5 * 0.5 18 
c3 - - 15 
c4 0.25 f. 0.05 5.2 k 0.5 6.5 
c5 _ - 0.83 
C6 0.28 k 0.05 5.5 f 0.5 0.65 
Cl 0.36 * 0.05 9.4 + 0.5 0.66 
C8 0.35 * 0.05 4.1 + 0.5 0.12 
Cl0 0.16 f 0.05 5.5 + 0.5 0.063 
Helix extension parameter is the slope of the plot of L/LO vs r, where L/LO is the 
ratio of the contour length of calf thymus DNA in the presence of the drug to the 
contour length in the absence of the ligand. Theoretically, an ideal 
monofunctional intercalator would give a plot with slope equal to 1. 
Measurements were made in a buffer of 2 0.01. Helix unwinding angles are 
expressed with respect o an equivalence binding ratio of 0.072, and an unwinding 
angle of 26”, for ethidium. Measurements were made in a buffer of 10.01. I& 
is the micromolar concentration of ligand that when added to cultures of L1210 
cells for a period of 70 h reduces cell numbers to 50% of control cultures 
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were corrected to binding ratios using the 
measured binding isotherms. With the exception of 
that for 4-aminoquinoline, helix extension plots 
are linear up to rvalues about 0.3 (not shown). The 
plot for 4-aminoquinoline becomes curvilinear, 
concave downward, above a binding ratio of 0.1. 
Representative data for the interaction of the C7 
diquinoline with closed circular DNA are shown in 
fig.3. The rise in reduced viscosity to about 27 dl/g 
for the fully relaxed circular DNA complex typifies 
the magnitude of the change caused by the other 
diquinolines. Binding ratios causing complete 
relaxation of supercoiling (termed the equivalence 
binding ratio) were deduced by correcting the ap- 
propriate drug to DNA input ratios using the 
binding isotherm for calf thymus DNA. Unwin- 
ding angles were calculated by comparison with 
ethidium whose unwinding angle is 26” [ 151, and 
whose equivalence binding ratio is 0.072 for this 
DNA under these experimental conditions [15]. 
The greatest helix extension of 2.0 A per bound 
ligand molecule (assuming a slope parameter of 1 
is equivalent to 3.4 A), is found for 
4arninoquinoline; C7 and CS diquinoline increase 
contour length by 1.2 A; the C2, C4 and C6 dimers 
by 0.9 A; and the Cl0 homologue by only 0.5 A. 
Similarly, helix unwinding angles fall into 
definable groups; those of 4-aminoquinoline, C2 
and C7 diquinoline lie in the vicinity of lo”, 
28 
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Fig.3. Effects of C7 diquinoline on the reduced viscosity of 
covalently closed circular pNZ116 DNA. The ordinate shows 
the reduced viscosity in dl/g and the abscissa the drug to DNA 
binding ratio expressed in base pairs. 
whereas those of the remaining compounds cluster 
around 5”. 
The diquinolines are growth inhibitory towards 
L1210 murine leukemia cells in culture, and their 
potency (I& values in the range of 18-0.06 PM) 
increases monotonically with increasing DNA af- 
finity and lipophilicity (see table 2). 
4. DISCUSSION 
The results of the viscometric and dialysis 
measurements clearly reveal 4aminoquinoline to 
be a weakly binding intercalating agent. Its un- 
winding angle and extension parameter are in- 
distinguishable from those observed for chloro- 
quine [l], whose intercalative mode of binding has 
been confirmed by NMR spectroscopy [16]. 
However, compared to its ,acridine analogue, 
9-aminoacridine, in a buffer of Z 0.01 its affinity is 
reduced 60-fold, its unwinding angle is halved and 
its binding induces only two-thirds of the increase 
in contour length [17,18]. In addition, given that 
the helix extension plot for 4-aminoquinoline is 
strongly bent above binding ratios of 0.1, and the 
fact that the measured binding isotherm reaches 
binding levels up to 0.63 at r/c values well above 
zero, it appears that the quinoline also binds by ex- 
ternal attachment o the DNA duplex. If so, the 
measured unwinding angle of 4-aminoquinoline 
may depend upon the binding ratio needed to 
reach equivalence in the circular DNA assay, and 
could thus appear to be a function of initial 
superhelix density (see [l] for a related argument 
concerning the ionic strength dependence of un- 
winding angles for quinolines). Hence, our value 
of 8” should be viewed as a lower limit since the 
equivalence point occurred at an r value well into 
the bent portion of the extension plot. 
Given the observed range of helix unwinding 
angles and extension parameters, it is clear that no 
member of this homologous series of diquinolines 
has the capacity for bifunctional intercalation. 
This is in stark contrast to the analogous diacridine 
series in which bisintercalation is found for the C6 
and higher homologues [19]. Indeed, the actual 
values of the unwinding and extension parameters 
suggest hat the C2 and C7 diquinolines intercalate 
monofunctionally, whereas the other derivatives 
are poor intercalators and interact with a fair pro- 
portion bound wholly externally. Unwinding 
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angles of a similar magnitude to those of C2 and 
C7 diquinoline have been reported for a 
bis-4-anilinoquinoline [20] and for the an- 
tibacterial agent dequalinium [21], a dimer com- 
prising 4-aminoquinaldine chromophores linked 
via ring nitrogens with a decane bridge. The small 
helix extension caused by monointercalated C2 and 
C7 diquinoline compared to 4-aminoquinoline is 
presumably related to DNA bending, kinking or 
base pair tilting at the binding site [22]. Since AT- 
base pair selectivity is a prominent feature of 
minor groove binding ligands [22], it seems 
probable that the selectivity of the diquinolines is 
a consequence of the non-intercalated chromo- 
phore interacting favourably with the narrow 
minor groove of AT-rich sequences. In this respect 
it is noteworthy that the bisintercalating dia- 
cridines show no sequence preferences [7]. 
Although the origins of the enhanced affinity of 
C2 diquinoline compared to 4aminoquinoline are 
self evident (dication compared to monocation, 
increased van der Waals interactions, etc.), the 
reason for the jump in affinity for the C7 and 
higher homologues is less obvious to us. Specula- 
tion on this point seems inappropriate in the 
absence of further structural information about 
the drug-DNA complexes. The efficacy of the di- 
quinolines in inhibiting the growth of leukaemia 
cells shows no obvious relationship to ther inter- 
calative capacity. This again contrasts with the 
behaviour of the diacridines which show a sharp 
increase in potency for the bisintercalating 
derivatives [2]. 
While virtually all cationic compounds contain- 
ing an acridine chromophore inter&ate into 
DNA, the binding mode of ligands possessing a 
quinoline ring is much more sensitive to molecular 
structure: thus, 4-aminoquinoline and chloroquine 
intercalate [ 1,161, whereas 4-anilinoquinoline does 
not [20]. Moreover, when the flexible poly- 
methylene linker chain of the diquinolines is 
replaced by a rigid cyclic depsipeptide, as is the 
case in the bisquinoline analogue of echinomycin 
[23] and luzopeptin [24] bisintercalation occurs. 
Our findings presented here, along with those of 
other workers, indicate that the quinoline ring is 
poised on the edge between intercalative and non- 
intercalative binding. At present we are in- 
vestigating the effects of chromophore sub- 
stituents, as well as the introduction of rigid 
240 
elements into the linker chain, on diquinoline bin- 
ding mode. 
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